GlaxoSmithKline Pharmaceuticals Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has GlaxoSmithKline Pharmaceuticals Limited's balance sheet done over the years? Its assets were worth $35,566,175,000 last year, which is less than in the previous period. 50% of GlaxoSmithKline Pharmaceuticals Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $17,789,778,000, which means an decrease by -10% compared compared to last year.
Debt to Assets
| 2012 | 30883991000 | 10.81B | 35.02% |
|---|---|---|---|
| 2013 | 31295235000 | 11.39B | 36.42% |
| 2015 | 32244246000 | 7.80B | 24.2% |
| 2016 | 30460135000 | 13.49B | 44.32% |
| 2018 | 39474827000 | 18.90B | 47.88% |
| 2019 | 39113109000 | 17.71B | 45.29% |
| 2020 | 31355410000 | 13.14B | 41.94% |
| 2021 | 31133608000 | 16.14B | 51.85% |
| 2022 | 46332778000 | 19.70B | 42.53% |
| 2024 | 35566175000 | 17.78B | 50.02% |
GLAXO.NS Balance Sheet (2013 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 641.71M | 2.86B | 4.05B | 1.04B | 987.76M | 12.70B | 13.22B | 1.15B | 20.22B | 20.49B |
Short term investments | 17.92B | 26.16B | 7.32B | 9.57B | 10.49B | -4.12B | 12.52B | 18.39B | 0 | 0 |
Net receivables | 2.22B | 2.66B | 5.13B | 2.23B | 3.63B | 0 | 0 | 0 | 2.54B | 3.12B |
Inventory | 5.25B | 5.34B | 5.46B | 4.83B | 4.86B | 5.00B | 5.25B | 3.75B | 3.46B | 2.85B |
Other current assets | 1.94B | 40.33M | 57.22M | 61.47M | 83.24M | 4.11B | 2.75B | 2.43B | 1.52M | 2.38M |
Total current assets | 27.98B | 37.08B | 22.02B | 17.74B | 20.06B | 21.81B | 21.72B | 25.74B | 26.23B | 26.46B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 3.10B | 3.25B | 3.54B | 8.27B | 13.67B | 11.73B | 4.71B | 2.38B | 1.61B | 1.33B |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 235.53M | 344.97M | 433.64M | 496.25M | 655.4M | 726.81M | 0 | 0 | 0 | 0 |
Long term investments | 34.18M | -26.24B | -7.28B | 3.70B | -10.48B | 4.12B | 66.00M | -18.39B | 0 | 0 |
Other non-current assets | 2.74B | 30.76B | 11.38B | 30.32M | 14.59B | 44.71M | 3.13B | 45.80M | 2.51B | 2.21B |
Total non-current assets | 7.58B | 9.25B | 9.10B | 13.60B | 19.05B | 17.66B | 8.73B | 6.50B | 5.05B | 4.41B |
Total assets | 35.56B | 46.33B | 31.13B | 31.35B | 39.11B | 39.47B | 30.46B | 32.24B | 31.29B | 30.88B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 75.50M | 43.47M | 8.36B | 6.34B | 10.33B | 10.73B | 6.55B | 1.74B | 5.92B | 5.86B |
Short term debt | 121.95M | 124.53M | 143.76M | 149.78M | 4.06M | 169.92M | 7.78M | 4.89M | 5.37M | 4.50M |
Total current liabilities | 15.24B | 16.98B | 13.32B | 10.24B | 14.54B | 15.99B | 10.57B | 5.00B | 8.88B | 8.36B |
| Non-current liabilities: | ||||||||||
Long term debt | 64.69M | 76.23M | 202.49M | 268.61M | 1.77M | 5.83M | 15.95M | 26.26M | 36.05M | 41.42M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 2.47B | 2.64B | 2.61B | 2.63B | 22.01M | 45.02M | 2.80B | 45.23M | 2.47B | 2.41B |
Total non-current liabilities | 2.54B | 2.71B | 2.81B | 2.90B | 3.17B | 2.90B | 2.92B | 2.80B | 2.50B | 2.45B |
Total liabilities | 17.78B | 19.70B | 16.14B | 13.14B | 17.71B | 18.90B | 13.49B | 7.80B | 11.39B | 10.81B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |